In fact, adiponectin, an anti-inflammatory adipokine, is decreased in MetS, and its decline parallels the increase in the number of MetS components an individual exhibits, coinciding with elevated inflammatory markers (48, 49). This evidence concerns the gene ADIPOQ and metabolic syndrome.